Abstract
Pathogenic yeasts of the genus Candida represent a serious threat to immunocompromised individuals. Soluble secreted aspartic proteinases produced by these opportunistic pathogens have been studied as one of the virulence factors and potential target for therapeutic intervention. Several structures of these enzymes in complex with inhibitors have been published; however, only a limited number of novel inhibitory compounds have been reported recently. Other members of aspartic proteinase family received less attention, although they are important for Candida survival in the host environment. Proteinases attached to the cell surface by GPI-anchor, as well as vacuolar aspartic proteinases may thus become promising therapeutic targets. This review summarizes the data available on less studied aspartic proteinases of C. albicans, and poses the question, whether the knowledge of vacuolar and GPI-anchored aspartic proteinases from Saccharomyces cerevisiae can inspire design of compounds inhibiting these types of enzymes in the pathogenic yeasts.
Keywords: Aspartic proteinase, Candida spp, GPI-anchored protein, IA3, Saccharomyces cerevisiae, secreted proteinase, vacuole, virulence factors, antimycotics, mycoses
Current Enzyme Inhibition
Title: Intracellular and Extracellular Aspartic Proteinases of Pathogenic Candida Species: Can their Inhibitors be Further Developed?
Volume: 7 Issue: 2
Author(s): Vaclava Bauerova, Zuzana Vinterova, Iva Pichova and Olga Hruskova-Heidingsfeldova
Affiliation:
Keywords: Aspartic proteinase, Candida spp, GPI-anchored protein, IA3, Saccharomyces cerevisiae, secreted proteinase, vacuole, virulence factors, antimycotics, mycoses
Abstract: Pathogenic yeasts of the genus Candida represent a serious threat to immunocompromised individuals. Soluble secreted aspartic proteinases produced by these opportunistic pathogens have been studied as one of the virulence factors and potential target for therapeutic intervention. Several structures of these enzymes in complex with inhibitors have been published; however, only a limited number of novel inhibitory compounds have been reported recently. Other members of aspartic proteinase family received less attention, although they are important for Candida survival in the host environment. Proteinases attached to the cell surface by GPI-anchor, as well as vacuolar aspartic proteinases may thus become promising therapeutic targets. This review summarizes the data available on less studied aspartic proteinases of C. albicans, and poses the question, whether the knowledge of vacuolar and GPI-anchored aspartic proteinases from Saccharomyces cerevisiae can inspire design of compounds inhibiting these types of enzymes in the pathogenic yeasts.
Export Options
About this article
Cite this article as:
Bauerova Vaclava, Vinterova Zuzana, Pichova Iva and Hruskova-Heidingsfeldova Olga, Intracellular and Extracellular Aspartic Proteinases of Pathogenic Candida Species: Can their Inhibitors be Further Developed?, Current Enzyme Inhibition 2011; 7 (2) . https://dx.doi.org/10.2174/157340811796575263
DOI https://dx.doi.org/10.2174/157340811796575263 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Endometriosis: The Role of Pharmacotherapy
Current Women`s Health Reviews An Update on the Cardiovascular Effects of Quercetin, a Plant Flavonoid
Current Nutrition & Food Science Problems in Statistical Analysis of Attrition in Randomized Controlled Clinical Trials of Antidepressant for Geriatric Depression
Current Psychiatry Reviews Antenatal Depression; its Prevalence of Positive Screen and the Associating Risk Factors Including Labor and Neonatal Outcome
Current Women`s Health Reviews Orchestrating HIV Neutralization by Secondary Immune Response- Mediated Induction of RF Antibodies
Current Immunology Reviews (Discontinued) Potential Therapeutic Effects of Physical Exercise for Bipolar Disorder
CNS & Neurological Disorders - Drug Targets An Investigation of the Anti-Parkinsonism Potential of Co-enzyme Q<sub>10</sub> and Co-enzyme Q<sub>10</sub> /Levodopa-carbidopa Combination in Mice
Current Aging Science Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer
Current Cancer Drug Targets Foreword: Apoptotic Mechanisms in Neurodegenerative Diseases
Current Alzheimer Research Clinical Pharmacology of Serotonin Receptor Type 3 (5-HT3) Antagonists
Current Medicinal Chemistry - Central Nervous System Agents Adolescent Admissions in Psychiatry: Reconsidering Clinical and Institutional Parameters on the Occasion of a Report of a Greek Experience
Adolescent Psychiatry Editorial (Thematic Issue: Modern Therapeutic Antibody Drug Discovery Technologies)
Current Drug Discovery Technologies Diagnosis and Management of Chronic Coronary Artery Disease
Current Cardiology Reviews Overview of Genomic Insights into Chicken Growth Traits Based on Genome- Wide Association Study and microRNA Regulation
Current Genomics Anti-Inflammatory and Antioxidant Properties of Piper Species: A Perspective from Screening to Molecular Mechanisms
Current Topics in Medicinal Chemistry A Systematic Review of Current Progresses in the Nucleic Acid-Based Therapies for Neurodegeneration with Implications for Alzheimer’s Disease
Mini-Reviews in Medicinal Chemistry Writers and Erasers of Histone Lysine methylation with Clinically Applied Modulators: Promising Target for Cancer Therapy
Current Pharmaceutical Design Opioid Antagonists for Pharmacological Treatment of Gambling Disorder: Are they Relevant?
Current Neuropharmacology Sedation in PACU: The Role of Propofol
Current Drug Targets Ganglioside Mimicry as a Cause of Guillain-Barre Syndrome
CNS & Neurological Disorders - Drug Targets